Form Type: 4

SEC EDGAR Link
Accession Number:0001104659-21-117446
Date:2021-09-16
Issuer: APREA THERAPEUTICS, INC. (APRE)
Original Submission Date:

Reporting Person:

ATTAR EYAL C.
535 BOYLSTON STREET
BOSTON, MA 02116

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-09-16 S 15,968 d $4.68 83,000 direct
COMMON STOCK 2021-09-16 0 $0.00 172 indirect f3
COMMON STOCK 2021-09-16 0 $0.00 159 indirect f3
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person.
f2 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $4.55 to $4.85 inclusive. the reporting person undertakes to provide aprea therapeutics, inc., any security holder of aprea therapeutics, inc., or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
f3 the reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of section 16 of the securities exchange act of 1934, or for any other purpose.

Elevate your investments